Aramark (ARMK) Q4 2026 Earnings Call Transcript

Aramark (ARMK) reported Q4 2026 revenue of $20.1B, up 10% YoY, with U.S. and international organic growth of 8% and 12%, respectively. Adjusted EPS grew 21% on a constant currency basis. The company announced a $1B share repurchase program and a 17% dividend increase. Key segments like Collegiate Hospitality and Healthcare Plus drove growth. Aramark Nexus contributed 1% to organic revenue growth, scaling premium hospitality services.

Original reporting
Published Nov 16, 2026, 5:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 5:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aramark (ARMK) Q4 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ARMKBullishMed
01

Why it matters

The most tradable elements are the board-approved $1 billion repurchase authorization and the 17% quarterly dividend increase, paired with quantified organic revenue and adjusted EPS growth plus commentary on new client wins and scaling of Aramark Nexus and Avendra.

02

Market read

Capital return expansion and reported growth acceleration can drive valuation and sentiment, while segment commentary and regulatory/project-timeline remarks shape expectations for fiscal 2027.

03

What to watch

The transcript references regulatory evolution and calendar-shift effects; traders may want to separate one-time items (incentive-based compensation charges) and watch for any commentary on margin durability and capex/FCF conversion.

Relevance 7/10Novelty 6/10Timing: during/after the Q4 2026 earnings call, with capital return details disclosed

Background

This is a transcript-style earnings call update for Aramark covering fiscal 2026 performance, Q4 segment drivers, and forward positioning for fiscal 2027.

Company-level read

Ticker impact

$ARMKBullishMedium confidence
Context

Aramark’s call discloses a new $1 billion share repurchase program and a 17% quarterly dividend increase alongside Q4 operating and EPS growth.

Expected impact

Likely upward bias as the market prices in higher shareholder yield and confidence in fiscal 2027 execution.

Evidence & confidence

The article includes explicit board-approved buyback size and dividend growth, plus quantified Q4 and fiscal 26 performance metrics that can influence valuation and expectations.

Market effects

Reinforces demand resilience in contract foodservice and hospitality outsourcing, with emphasis on collegiate, workplace, healthcare, and sports verticals.

Highlights international growth drivers in Canada, the U.K., and Chile, which may modestly affect regional peers’ sentiment.

Signals continued scaling of procurement/GPO capabilities (Avendra) and premium hospitality offerings, relevant to global contract catering and facilities services demand.

Counterpoint

Buyback and dividend increases may be partially offset by uncertainty around project timelines and incentive-based compensation charges, so investors may discount the quality of underlying earnings power.

Key entities

  • Aramark

    Contract foodservice and hospitality services provider; disclosed a new $1 billion buyback and a 17% quarterly dividend increase during its Q4 2026 earnings call.

Related articles

$ARMKMed

Aramark Q4 2026 Earnings Call Summary

Aramark reported record annualized gross new client wins of $1.9 billion, a 97% client retention rate, and launched Aramark Nexus. The company reduced its leverage ratio to 2.7x, enabling a $1 billion share repurchase program and a 17% dividend increase. For fiscal 2027, Aramark projects $500 million in revenue from Nexus, 9-10% organic revenue growth, and 15-19% adjusted operating income growth. Management highlighted supply chain efficiencies and mitigating inflation impacts.

$ARMKHigh

Why is Aramark stock sliding today?

Aramark (ARMK) shares fell 4.7% pre-market after reporting Q4 2026 results that missed estimates, with adjusted EPS at $0.71 vs. $0.75 and revenue at $5.29B vs. $5.30B. The company's fiscal 2027 guidance also fell short of expectations. Despite a 25% YoY EPS increase and 4.8% revenue growth, the stock dropped due to broader market pressures and the earnings miss.

$ARMKMedAI 8/10

Aramark Q4 Results Climb, Sees Growth In FY27; Lifts Dividend, Plans $1 Bln Buyback; But Stock Down

Aramark (ARMK) reported Q4 profit and revenue growth, with net earnings rising to $137.94M ($0.51 per share) from $87.14M ($0.33 per share) a year ago. The company projects FY27 organic EPS growth of 20-25%, operating income growth of 15-19%, and revenue growth of 9-10%. It also announced a $1B share buyback program and a 17% dividend increase. Shares were down 5.45% in pre-market trading.